Correction: Recombinant RBD-based subunit vaccines incorporating high-frequency mutation sites elicit cross-immunity and robust protection against SARS-CoV-2
{{output}}
[This corrects the article DOI: 10.3389/fmicb.2026.1806270.]. Keywords: RBD; SARS-CoV-2; high-frequency SARS-CoV-2 RBD mutation ... ...
